Next generation diagnostic molecular pathology: critical appraisal of quality assurance in Europe.

@article{Dubbink2014NextGD,
  title={Next generation diagnostic molecular pathology: critical appraisal of quality assurance in Europe.},
  author={Hendrikus Jan Dubbink and Zandra C. Deans and Bastiaan B. J. Tops and Folkert J van Kemenade and Senada Koljenovi{\'c} and Han H van Krieken and Willeke A. M. Blokx and Winand N. M. Dinjens and Patricia J. T. A. Groenen},
  journal={Molecular oncology},
  year={2014},
  volume={8 4},
  pages={
          830-9
        }
}
Tumor evaluation in pathology is more and more based on a combination of traditional histopathology and molecular analysis. Due to the rapid development of new cancer treatments that specifically target aberrant proteins present in tumor cells, treatment decisions are increasingly based on the molecular features of the tumor. Not only the number of patients eligible for targeted precision medicine, but also the number of molecular targets per patient and tumor type is rising. Diagnostic… CONTINUE READING
Highly Cited
This paper has 20 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 44 references

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.

The New England journal of medicine • 2013
View 8 Excerpts
Highly Influenced

Europe does it better: molecular testing across a national health care system-the French example.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting • 2013
View 4 Excerpts
Highly Influenced

Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours

N. I. Lindeman, P. T. Cagle, M. B. Beasley
Histopathology • 2013
View 1 Excerpt

Improvement in the quality of molecular analysis of EGFR in non - small - cell lung cancer detected by three rounds of external quality assessment

Z. C. Deans, A. Wallace, B. O’Sullivan
J . Clin . Path • 2013
View 3 Excerpts

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment , for the BRAF EQA group

V. Endris, R. Penzel, A. Warth
BMC Cancer • 2013
View 1 Excerpt